首页> 外文期刊>BMC Immunology >Extracellular signal-regulated kinase 1/2 is required for complement component C1q and fibronectin dependent enhancement of Fcγ- receptor mediated phagocytosis in mouse and human cells
【24h】

Extracellular signal-regulated kinase 1/2 is required for complement component C1q and fibronectin dependent enhancement of Fcγ- receptor mediated phagocytosis in mouse and human cells

机译:补体组分C1Q和纤连蛋白依赖性增强Fcγ-受体介导的小鼠和人细胞的吞噬作用所需的细胞外信号调节激酶1/2

获取原文
           

摘要

C1q is a soluble pattern recognition protein that regulates multiple leukocyte functions, and deficiency in C1q results in autoimmunity. C1q stimulates enhanced phagocytic function through multiple mechanisms including the rapid enhancement of Fcγ receptor (FcγR) -mediated phagocytosis. The molecular mechanism responsible for this rapid enhancement of phagocytic function is unknown. The purpose of this study was to investigate the molecular pathway required for C1q-dependent enhanced phagocytosis. Leukocyte associated immunoglobulin like receptor-1 (LAIR-1) is a receptor that mediates C1q-dependent activation of leukocytes; however, using LAIR-1 deficient mouse bone marrow derived macrophages (BMDM), we demonstrated that LAIR-1 was not required for C1q-dependent enhanced FcγR-mediated phagocytosis. A phospho-kinase array identified extracellular signal-regulated kinase (ERK) 1/2 as dysregulated following activation with C1q. Validation of the array in BMDM and the human monocyte cell line THP-1 demonstrated a decrease in basal ERK1/2 phosphorylation in C1q-stimulated cells compared to control cells. However, subsequent stimulation with immune complexes stimulated rapid upregulation of phosphorylation. The extracellular matrix protein fibronectin regulates enhanced phagocytic activity in macrophages similar to C1q, and both C1q and fibronectin-dependent enhanced phagocytosis required ERK1/2 since both were blocked by pharmacologic inhibition of ERK1/2. Furthermore, diminished C1q-dependent ERK1/2 phosphorylation was sustained after four-hour treatment with lipopolysaccharide and correlated with a significant reduction in TNFα production. These data demonstrate that C1q and fibronectin utilize a similar ERK1/2-dependent mechanism for enhanced phagocytosis, which should lead to development of novel approaches to modulate C1q-dependent regulation of macrophage activation, inflammation and autoimmunity.
机译:C1Q是一种可溶性模式识别蛋白,调节多种白细胞功能,C1Q缺乏导致自身免疫。 C1Q通过多种机制刺激增强的吞噬功能,包括快速增强Fcγ受体(FcγR)介导的吞噬作用。负责这种快速增强吞噬功能的分子机制是未知的。本研究的目的是研究C1Q依赖性增强吞噬作用所需的分子途径。白细胞相关免疫球蛋白如受体-1(Lair-1)是介导白细胞的C1Q依赖性活化的受体;然而,使用丽脂1缺乏小鼠骨髓衍生的巨噬细胞(BMDM),我们证明了C1Q依赖性增强的FCγR介导的吞噬作用不需要唇疱疹。磷酸激酶阵列将细胞外信号调节的激酶(ERK)1/2鉴定为在用C1Q激活后的失调。与对照细胞相比,BMDM中阵列和人单核细胞系细胞系THP-1的验证证明了C1Q刺激细胞中基础ERK1 / 2磷酸化的降低。然而,随后用免疫复合物刺激刺激磷酸化的快速上调。细胞外基质蛋白纤连蛋白调节与C1Q相似的巨噬细胞中增强的吞噬活性,并且C1Q和纤连蛋白依赖性增强的吞噬作用需要ERK1 / 2,因为两者都被ERK1 / 2的药理学抑制阻断。此外,在用脂多糖四小时处理后,C1Q依赖性ERK1 / 2磷酸化依赖于C1Q依赖性ERK1 / 2磷酸化,并与TNFα产生的显着降低相关。这些数据表明C1Q和Fibronectin利用类似的ERK1 / 2依赖性机制来增强吞噬作用,这应该导致新型方法的调节C1Q依赖性调节巨噬细胞激活,炎症和自身免疫调节。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号